Stereochemistry of an agonist determines coupling preference of β 2-adrenoceptor to different g proteins in cardiomyocytes

Anthony Yiu Ho Woo, Tian Bing Wang, Xiaokun Zeng, Weizhong Zhu, Darrell R. Abernethy, Irving W. Wainer, Rui Ping Xiao

Research output: Contribution to journalArticle

Abstract

A fundamental question regarding receptor-G protein interaction is whether different agonists can lead a receptor to different intracellular signaling pathways. Our previous studies have demonstrated that although most β 2-adrenoceptor agonists activate both G s and G i proteins, fenoterol, a full agonist of β 2- adrenoceptor, selectively activates G s protein. Fenoterol contains two chiral centers and may exist as four stereoisomers. We have synthesized a series of stereoisomers of fenoterol and its derivatives and characterized their receptor binding and pharmacological properties. We tested the hypothesis that the stereochemistry of an agonist determines selectivity of receptor coupling to different G protein(s). We found that the R,R isomers of fenoterol and methoxyfenoterol exhibited more potent effects to increase car-diomyocyte contraction than their S,R isomers. It is noteworthy that although (R,R)-fenoterol and (R,R)-methoxyfenoterol preferentially activate G s signaling, their S,R isomers were able to activate both G s and G i proteins as evidenced by the robust pertussis toxin sensitivities of their effects on cardiomyocyte contraction and on phosphorylation of extracellular signal-regulated kinase 1/2. The differential G protein selectivities of the fenoterol stereo-isomers were further confirmed by photoaffinity labeling studies on G s,G i2, and G i3 proteins. The inefficient G i signaling with the R,R isomers is not caused by the inability of the R,R isomers to trigger the protein kinase A (PKA)-mediated phosphorylation of the β 2-adrenoceptor, because the R,R isomers also markedly increased phosphorylation of the receptor at serine 262 by PKA. We conclude that in addition to receptor subtype and phosphor-ylation status, the stereochemistry of a given agonist plays an important role in determining receptor-G protein selectivity and downstream signaling events.

Original languageEnglish (US)
Pages (from-to)158-165
Number of pages8
JournalMolecular Pharmacology
Volume75
Issue number1
DOIs
StatePublished - Jan 2009
Externally publishedYes

Fingerprint

Fenoterol
Cardiac Myocytes
Adrenergic Receptors
GTP-Binding Proteins
Proteins
Stereoisomerism
Phosphorylation
Cyclic AMP-Dependent Protein Kinases
Mitogen-Activated Protein Kinase 3
Mitogen-Activated Protein Kinase 1
Pertussis Toxin
Pharmacology

ASJC Scopus subject areas

  • Pharmacology
  • Molecular Medicine

Cite this

Woo, A. Y. H., Wang, T. B., Zeng, X., Zhu, W., Abernethy, D. R., Wainer, I. W., & Xiao, R. P. (2009). Stereochemistry of an agonist determines coupling preference of β 2-adrenoceptor to different g proteins in cardiomyocytes. Molecular Pharmacology, 75(1), 158-165. https://doi.org/10.1124/mol.108.051078

Stereochemistry of an agonist determines coupling preference of β 2-adrenoceptor to different g proteins in cardiomyocytes. / Woo, Anthony Yiu Ho; Wang, Tian Bing; Zeng, Xiaokun; Zhu, Weizhong; Abernethy, Darrell R.; Wainer, Irving W.; Xiao, Rui Ping.

In: Molecular Pharmacology, Vol. 75, No. 1, 01.2009, p. 158-165.

Research output: Contribution to journalArticle

Woo, Anthony Yiu Ho ; Wang, Tian Bing ; Zeng, Xiaokun ; Zhu, Weizhong ; Abernethy, Darrell R. ; Wainer, Irving W. ; Xiao, Rui Ping. / Stereochemistry of an agonist determines coupling preference of β 2-adrenoceptor to different g proteins in cardiomyocytes. In: Molecular Pharmacology. 2009 ; Vol. 75, No. 1. pp. 158-165.
@article{4cc22c8d1cdd4ef2aac8aaeca8cc48c0,
title = "Stereochemistry of an agonist determines coupling preference of β 2-adrenoceptor to different g proteins in cardiomyocytes",
abstract = "A fundamental question regarding receptor-G protein interaction is whether different agonists can lead a receptor to different intracellular signaling pathways. Our previous studies have demonstrated that although most β 2-adrenoceptor agonists activate both G s and G i proteins, fenoterol, a full agonist of β 2- adrenoceptor, selectively activates G s protein. Fenoterol contains two chiral centers and may exist as four stereoisomers. We have synthesized a series of stereoisomers of fenoterol and its derivatives and characterized their receptor binding and pharmacological properties. We tested the hypothesis that the stereochemistry of an agonist determines selectivity of receptor coupling to different G protein(s). We found that the R,R isomers of fenoterol and methoxyfenoterol exhibited more potent effects to increase car-diomyocyte contraction than their S,R isomers. It is noteworthy that although (R,R)-fenoterol and (R,R)-methoxyfenoterol preferentially activate G s signaling, their S,R isomers were able to activate both G s and G i proteins as evidenced by the robust pertussis toxin sensitivities of their effects on cardiomyocyte contraction and on phosphorylation of extracellular signal-regulated kinase 1/2. The differential G protein selectivities of the fenoterol stereo-isomers were further confirmed by photoaffinity labeling studies on G s,G i2, and G i3 proteins. The inefficient G i signaling with the R,R isomers is not caused by the inability of the R,R isomers to trigger the protein kinase A (PKA)-mediated phosphorylation of the β 2-adrenoceptor, because the R,R isomers also markedly increased phosphorylation of the receptor at serine 262 by PKA. We conclude that in addition to receptor subtype and phosphor-ylation status, the stereochemistry of a given agonist plays an important role in determining receptor-G protein selectivity and downstream signaling events.",
author = "Woo, {Anthony Yiu Ho} and Wang, {Tian Bing} and Xiaokun Zeng and Weizhong Zhu and Abernethy, {Darrell R.} and Wainer, {Irving W.} and Xiao, {Rui Ping}",
year = "2009",
month = "1",
doi = "10.1124/mol.108.051078",
language = "English (US)",
volume = "75",
pages = "158--165",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Stereochemistry of an agonist determines coupling preference of β 2-adrenoceptor to different g proteins in cardiomyocytes

AU - Woo, Anthony Yiu Ho

AU - Wang, Tian Bing

AU - Zeng, Xiaokun

AU - Zhu, Weizhong

AU - Abernethy, Darrell R.

AU - Wainer, Irving W.

AU - Xiao, Rui Ping

PY - 2009/1

Y1 - 2009/1

N2 - A fundamental question regarding receptor-G protein interaction is whether different agonists can lead a receptor to different intracellular signaling pathways. Our previous studies have demonstrated that although most β 2-adrenoceptor agonists activate both G s and G i proteins, fenoterol, a full agonist of β 2- adrenoceptor, selectively activates G s protein. Fenoterol contains two chiral centers and may exist as four stereoisomers. We have synthesized a series of stereoisomers of fenoterol and its derivatives and characterized their receptor binding and pharmacological properties. We tested the hypothesis that the stereochemistry of an agonist determines selectivity of receptor coupling to different G protein(s). We found that the R,R isomers of fenoterol and methoxyfenoterol exhibited more potent effects to increase car-diomyocyte contraction than their S,R isomers. It is noteworthy that although (R,R)-fenoterol and (R,R)-methoxyfenoterol preferentially activate G s signaling, their S,R isomers were able to activate both G s and G i proteins as evidenced by the robust pertussis toxin sensitivities of their effects on cardiomyocyte contraction and on phosphorylation of extracellular signal-regulated kinase 1/2. The differential G protein selectivities of the fenoterol stereo-isomers were further confirmed by photoaffinity labeling studies on G s,G i2, and G i3 proteins. The inefficient G i signaling with the R,R isomers is not caused by the inability of the R,R isomers to trigger the protein kinase A (PKA)-mediated phosphorylation of the β 2-adrenoceptor, because the R,R isomers also markedly increased phosphorylation of the receptor at serine 262 by PKA. We conclude that in addition to receptor subtype and phosphor-ylation status, the stereochemistry of a given agonist plays an important role in determining receptor-G protein selectivity and downstream signaling events.

AB - A fundamental question regarding receptor-G protein interaction is whether different agonists can lead a receptor to different intracellular signaling pathways. Our previous studies have demonstrated that although most β 2-adrenoceptor agonists activate both G s and G i proteins, fenoterol, a full agonist of β 2- adrenoceptor, selectively activates G s protein. Fenoterol contains two chiral centers and may exist as four stereoisomers. We have synthesized a series of stereoisomers of fenoterol and its derivatives and characterized their receptor binding and pharmacological properties. We tested the hypothesis that the stereochemistry of an agonist determines selectivity of receptor coupling to different G protein(s). We found that the R,R isomers of fenoterol and methoxyfenoterol exhibited more potent effects to increase car-diomyocyte contraction than their S,R isomers. It is noteworthy that although (R,R)-fenoterol and (R,R)-methoxyfenoterol preferentially activate G s signaling, their S,R isomers were able to activate both G s and G i proteins as evidenced by the robust pertussis toxin sensitivities of their effects on cardiomyocyte contraction and on phosphorylation of extracellular signal-regulated kinase 1/2. The differential G protein selectivities of the fenoterol stereo-isomers were further confirmed by photoaffinity labeling studies on G s,G i2, and G i3 proteins. The inefficient G i signaling with the R,R isomers is not caused by the inability of the R,R isomers to trigger the protein kinase A (PKA)-mediated phosphorylation of the β 2-adrenoceptor, because the R,R isomers also markedly increased phosphorylation of the receptor at serine 262 by PKA. We conclude that in addition to receptor subtype and phosphor-ylation status, the stereochemistry of a given agonist plays an important role in determining receptor-G protein selectivity and downstream signaling events.

UR - http://www.scopus.com/inward/record.url?scp=58849137169&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58849137169&partnerID=8YFLogxK

U2 - 10.1124/mol.108.051078

DO - 10.1124/mol.108.051078

M3 - Article

C2 - 18838481

AN - SCOPUS:58849137169

VL - 75

SP - 158

EP - 165

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 1

ER -